522 related articles for article (PubMed ID: 26068650)
1. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
Poljak M
Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
[No Abstract] [Full Text] [Related]
2. Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.
Bornstein J; Fisher WA; Ginsberg GM; Shavit O; Schejter E; Diaz M; Bosch FX
Vaccine; 2013 Nov; 31 Suppl 8():I58-60. PubMed ID: 24229721
[No Abstract] [Full Text] [Related]
3. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
Poljak M
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
5. [The advantage of a specialized HPV clinic within the department of proctology].
Skala K; Zufferey G; Robert-Yap J; Morel P; Roche B
Rev Med Suisse; 2011 Jun; 7(300):1348-50, 1352-3. PubMed ID: 21815534
[TBL] [Abstract][Full Text] [Related]
6. HPV vaccines: what remains to be done? Interview by Lauren Constable.
Zur Hausen H
Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
[No Abstract] [Full Text] [Related]
7. Prevention of cervical cancer in Central and Eastern Europe and Central Asia: a challenge for the future.
Kesic V
Vaccine; 2013 Dec; 31 Suppl 7():vii-ix. PubMed ID: 24332301
[No Abstract] [Full Text] [Related]
8. European consensus statement on "HPV Vaccination and Colposcopy".
Shafi MI; Petry U; Bosch XF; Gissman L; Kocken M; Helmerhorst TJ; Stanley M; Nazeer S; European Federation for Colposcopy
J Low Genit Tract Dis; 2011 Oct; 15(4):309-15. PubMed ID: 21959574
[TBL] [Abstract][Full Text] [Related]
9. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
10. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
11. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
12. HPV testing and vaccination in Europe.
Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
[TBL] [Abstract][Full Text] [Related]
13. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
Chelimo C; Wouldes TA; Cameron LD; Elwood JM
J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
[TBL] [Abstract][Full Text] [Related]
16. Public Health Benefits of Routine Human Papillomavirus Vaccination for Adults in the Netherlands: A Mathematical Modeling Study.
Matthijsse SM; Hontelez JA; Naber SK; Rozemeijer K; de Kok IM; Bakker R; van Ballegooijen M; van Rosmalen J; de Vlas SJ
J Infect Dis; 2016 Sep; 214(6):854-61. PubMed ID: 27330051
[TBL] [Abstract][Full Text] [Related]
17. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of cervical cancer. Screening and vaccination: methods of use].
Boulanger JC
Gynecol Obstet Fertil; 2011; 39(7-8):405-6. PubMed ID: 21757389
[No Abstract] [Full Text] [Related]
19. [Implementation of HPV vaccination in Germany].
Schreckenberger C; Kaufmann AM; Schneider A
Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
[No Abstract] [Full Text] [Related]
20. Prophylactic HPV vaccination for the prevention of cervical cancer.
Hernandez BY
Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
